Industry Research Reports
Part 1
Part 2
Part 3
Part 4
Part 5
Home > Reports > Service & Software > Cell and Gene Supply Chain Solutions - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Cell and Gene Supply Chain Solutions - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Description
Cell and gene supply chain solutions help mitigate distribution risks with features designed to improve product handling and unforeseen disruptions.Goods and services are produced and sold as inexpensively as possible, in quantities demanded by the market.
The global market for Cell and Gene Supply Chain Solutions was estimated to be worth US$ 1230 million in 2023 and is forecast to a readjusted size of US$ 1816.6 million by 2030 with a CAGR of 5.6% during the forecast period 2024-2030
Cell and Gene Supply Chain Solutions Market Size(US$)
M= millions and B=billions
The global cell and gene supply chain solutions market refers to the industry that provides specialized logistics, storage, and distribution services for cell and gene therapies. These therapies involve the use of living cells or genetic material to treat, cure, or prevent diseases. As cell and gene therapies gain momentum, the need for efficient and reliable supply chain solutions becomes crucial. Here’s an overview of the market:
Market Overview: The cell and gene supply chain solutions market has experienced significant growth in recent years due to the rapid development and commercialization of cell and gene therapies. These therapies, which include gene editing, cell-based immunotherapies, regenerative medicine, and gene therapies, require proper handling, storage, transportation, and tracking to ensure their integrity and efficacy.
Challenges in the Supply Chain: Cell and gene therapies have unique requirements that pose challenges to the supply chain. These challenges include maintaining the integrity of living cells or genetic materials during transportation, ensuring proper storage conditions, managing the complex logistics of personalized therapies, complying with regulatory requirements, and establishing effective traceability systems.
Supply Chain Solutions: Companies in the cell and gene supply chain solutions market offer a range of services to address these challenges. These services include specialized cold chain logistics, temperature-controlled storage facilities, cryopreservation solutions, packaging and labeling, transportation management, and real-time monitoring of therapies throughout the supply chain. Additionally, they provide expertise in regulatory compliance and documentation required for cell and gene therapies.
Market Players: The market for cell and gene supply chain solutions is comprised of various stakeholders, including logistics companies, specialized courier services, storage and distribution providers, and technology providers. Some companies focus solely on cell and gene therapies, while others offer supply chain solutions for a broader range of healthcare products.
Integration of Technology: Technology plays a key role in optimizing the cell and gene supply chain. Companies leverage advanced information systems, data analytics, and real-time monitoring solutions to ensure the safe and timely delivery of therapies. Furthermore, emerging technologies such as blockchain are being explored to enhance traceability and transparency in the supply chain.
Regulatory Environment: The cell and gene supply chain solutions market is influenced by regulatory frameworks governing the transportation, storage, and distribution of biological products, including cell and gene therapies. Companies in this market need to adhere to quality and safety standards, maintain documentation and traceability, and comply with regulations specific to each region or country.
Collaboration and Partnerships: Due to the complexity of cell and gene therapies, collaborations and partnerships between different stakeholders are crucial. This includes collaborations between therapy developers, logistics providers, storage facilities, and clinical sites to ensure efficient supply chain management and seamless delivery of therapies to patients.
Market Outlook: The global cell and gene supply chain solutions market is expected to experience substantial growth in the coming years. Factors driving this growth include the increasing number of approved cell and gene therapies, advancements in cold chain and storage technologies, growing investments in the biopharmaceutical sector, and rising demand for personalized medicine.The global cell and gene supply chain solutions market refers to the industry that provides specialized logistics, storage, and distribution services for cell and gene therapies. These therapies involve the use of living cells or genetic material to treat, cure, or prevent diseases. As cell and gene therapies gain momentum, the need for efficient and reliable supply chain solutions becomes crucial. Here’s an overview of the market:
Market Overview: The cell and gene supply chain solutions market has experienced significant growth in recent years due to the rapid development and commercialization of cell and gene therapies. These therapies, which include gene editing, cell-based immunotherapies, regenerative medicine, and gene therapies, require proper handling, storage, transportation, and tracking to ensure their integrity and efficacy.
Challenges in the Supply Chain: Cell and gene therapies have unique requirements that pose challenges to the supply chain. These challenges include maintaining the integrity of living cells or genetic materials during transportation, ensuring proper storage conditions, managing the complex logistics of personalized therapies, complying with regulatory requirements, and establishing effective traceability systems.
Supply Chain Solutions: Companies in the cell and gene supply chain solutions market offer a range of services to address these challenges. These services include specialized cold chain logistics, temperature-controlled storage facilities, cryopreservation solutions, packaging and labeling, transportation management, and real-time monitoring of therapies throughout the supply chain. Additionally, they provide expertise in regulatory compliance and documentation required for cell and gene therapies.
Market Players: The market for cell and gene supply chain solutions is comprised of various stakeholders, including logistics companies, specialized courier services, storage and distribution providers, and technology providers. Some companies focus solely on cell and gene therapies, while others offer supply chain solutions for a broader range of healthcare products.
Integration of Technology: Technology plays a key role in optimizing the cell and gene supply chain. Companies leverage advanced information systems, data analytics, and real-time monitoring solutions to ensure the safe and timely delivery of therapies. Furthermore, emerging technologies such as blockchain are being explored to enhance traceability and transparency in the supply chain.
Regulatory Environment: The cell and gene supply chain solutions market is influenced by regulatory frameworks governing the transportation, storage, and distribution of biological products, including cell and gene therapies. Companies in this market need to adhere to quality and safety standards, maintain documentation and traceability, and comply with regulations specific to each region or country.
Collaboration and Partnerships: Due to the complexity of cell and gene therapies, collaborations and partnerships between different stakeholders are crucial. This includes collaborations between therapy developers, logistics providers, storage facilities, and clinical sites to ensure efficient supply chain management and seamless delivery of therapies to patients.
Market Outlook: The global cell and gene supply chain solutions market is expected to experience substantial growth in the coming years. Factors driving this growth include the increasing number of approved cell and gene therapies, advancements in cold chain and storage technologies, growing investments in the biopharmaceutical sector, and rising demand for personalized medicine.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cell and Gene Supply Chain Solutions, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Cell and Gene Supply Chain Solutions by region & country, by Type, and by Application.
The Cell and Gene Supply Chain Solutions market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell and Gene Supply Chain Solutions.
Market Segmentation
Report Metric
Details
Report Title
Cell and Gene Supply Chain Solutions - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Forecasted Market Size in 2030
US$ 1816.6 million
CAGR(2024-2030)
5.6%
Market Size Available for Years
2024-2030
Global Cell and Gene Supply Chain Solutions Companies Covered
Arvato
Biocair
CSafe Global, LLC
Catalent
BioLife Solutions
BioTherapies
Azenta US, Inc.
Clarkston Consulting
Cryoport
Haemonetics
Hypertrust Patient Data Care
Lykan Bioscience
MAK-SYSTEM International Group
MasterControl, Inc.
SAP
SAVSU Technologies, Inc.
sedApta Group
Stafa Cellular Therapy
Title21 Health Solutions
TraceLink, Inc.
TrakCel Limited
Vineti, Inc
Global Cell and Gene Supply Chain Solutions Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cell and Gene Supply Chain Solutions Market, Segment by Type
Cloud-Based
On-Premises
Global Cell and Gene Supply Chain Solutions Market, Segment by Application
Biobank/ Cell-bank
Hospitals
Research Institutes
Cell Therapy Labs
Others
Forecast Units
Million USD
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Cell and Gene Supply Chain Solutions manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Cell and Gene Supply Chain Solutions in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Cell and Gene Supply Chain Solutions in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Cell and Gene Supply Chain Solutions Product Introduction
1.2 Global Cell and Gene Supply Chain Solutions Market Size Forecast
1.3 Cell and Gene Supply Chain Solutions Market Trends & Drivers
1.3.1 Cell and Gene Supply Chain Solutions Industry Trends
1.3.2 Cell and Gene Supply Chain Solutions Market Drivers & Opportunity
1.3.3 Cell and Gene Supply Chain Solutions Market Challenges
1.3.4 Cell and Gene Supply Chain Solutions Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Cell and Gene Supply Chain Solutions Players Revenue Ranking (2023)
2.2 Global Cell and Gene Supply Chain Solutions Revenue by Company (2019-2024)
2.3 Key Companies Cell and Gene Supply Chain Solutions Manufacturing Base Distribution and Headquarters
2.4 Key Companies Cell and Gene Supply Chain Solutions Product Offered
2.5 Key Companies Time to Begin Mass Production of Cell and Gene Supply Chain Solutions
2.6 Cell and Gene Supply Chain Solutions Market Competitive Analysis
2.6.1 Cell and Gene Supply Chain Solutions Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Cell and Gene Supply Chain Solutions Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Supply Chain Solutions as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Cloud-Based
3.1.2 On-Premises
3.2 Global Cell and Gene Supply Chain Solutions Sales Value by Type
3.2.1 Global Cell and Gene Supply Chain Solutions Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Cell and Gene Supply Chain Solutions Sales Value, by Type (2019-2030)
3.2.3 Global Cell and Gene Supply Chain Solutions Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Biobank/ Cell-bank
4.1.2 Hospitals
4.1.3 Research Institutes
4.1.4 Cell Therapy Labs
4.1.5 Others
4.2 Global Cell and Gene Supply Chain Solutions Sales Value by Application
4.2.1 Global Cell and Gene Supply Chain Solutions Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Cell and Gene Supply Chain Solutions Sales Value, by Application (2019-2030)
4.2.3 Global Cell and Gene Supply Chain Solutions Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Cell and Gene Supply Chain Solutions Sales Value by Region
5.1.1 Global Cell and Gene Supply Chain Solutions Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Cell and Gene Supply Chain Solutions Sales Value by Region (2019-2024)
5.1.3 Global Cell and Gene Supply Chain Solutions Sales Value by Region (2025-2030)
5.1.4 Global Cell and Gene Supply Chain Solutions Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Cell and Gene Supply Chain Solutions Sales Value, 2019-2030
5.2.2 North America Cell and Gene Supply Chain Solutions Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Cell and Gene Supply Chain Solutions Sales Value, 2019-2030
5.3.2 Europe Cell and Gene Supply Chain Solutions Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Cell and Gene Supply Chain Solutions Sales Value, 2019-2030
5.4.2 Asia Pacific Cell and Gene Supply Chain Solutions Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Cell and Gene Supply Chain Solutions Sales Value, 2019-2030
5.5.2 South America Cell and Gene Supply Chain Solutions Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Cell and Gene Supply Chain Solutions Sales Value, 2019-2030
5.6.2 Middle East & Africa Cell and Gene Supply Chain Solutions Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Cell and Gene Supply Chain Solutions Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Cell and Gene Supply Chain Solutions Sales Value
6.3 United States
6.3.1 United States Cell and Gene Supply Chain Solutions Sales Value, 2019-2030
6.3.2 United States Cell and Gene Supply Chain Solutions Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Cell and Gene Supply Chain Solutions Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Cell and Gene Supply Chain Solutions Sales Value, 2019-2030
6.4.2 Europe Cell and Gene Supply Chain Solutions Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Cell and Gene Supply Chain Solutions Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Cell and Gene Supply Chain Solutions Sales Value, 2019-2030
6.5.2 China Cell and Gene Supply Chain Solutions Sales Value by Type (%), 2023 VS 2030
6.5.3 China Cell and Gene Supply Chain Solutions Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Cell and Gene Supply Chain Solutions Sales Value, 2019-2030
6.6.2 Japan Cell and Gene Supply Chain Solutions Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Cell and Gene Supply Chain Solutions Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Cell and Gene Supply Chain Solutions Sales Value, 2019-2030
6.7.2 South Korea Cell and Gene Supply Chain Solutions Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Cell and Gene Supply Chain Solutions Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Cell and Gene Supply Chain Solutions Sales Value, 2019-2030
6.8.2 Southeast Asia Cell and Gene Supply Chain Solutions Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Cell and Gene Supply Chain Solutions Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Cell and Gene Supply Chain Solutions Sales Value, 2019-2030
6.9.2 India Cell and Gene Supply Chain Solutions Sales Value by Type (%), 2023 VS 2030
6.9.3 India Cell and Gene Supply Chain Solutions Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Arvato
7.1.1 Arvato Profile
7.1.2 Arvato Main Business
7.1.3 Arvato Cell and Gene Supply Chain Solutions Products, Services and Solutions
7.1.4 Arvato Cell and Gene Supply Chain Solutions Revenue (US$ Million) & (2019-2024)
7.1.5 Arvato Recent Developments
7.2 Biocair
7.2.1 Biocair Profile
7.2.2 Biocair Main Business
7.2.3 Biocair Cell and Gene Supply Chain Solutions Products, Services and Solutions
7.2.4 Biocair Cell and Gene Supply Chain Solutions Revenue (US$ Million) & (2019-2024)
7.2.5 Biocair Recent Developments
7.3 CSafe Global, LLC
7.3.1 CSafe Global, LLC Profile
7.3.2 CSafe Global, LLC Main Business
7.3.3 CSafe Global, LLC Cell and Gene Supply Chain Solutions Products, Services and Solutions
7.3.4 CSafe Global, LLC Cell and Gene Supply Chain Solutions Revenue (US$ Million) & (2019-2024)
7.3.5 Catalent Recent Developments
7.4 Catalent
7.4.1 Catalent Profile
7.4.2 Catalent Main Business
7.4.3 Catalent Cell and Gene Supply Chain Solutions Products, Services and Solutions
7.4.4 Catalent Cell and Gene Supply Chain Solutions Revenue (US$ Million) & (2019-2024)
7.4.5 Catalent Recent Developments
7.5 BioLife Solutions
7.5.1 BioLife Solutions Profile
7.5.2 BioLife Solutions Main Business
7.5.3 BioLife Solutions Cell and Gene Supply Chain Solutions Products, Services and Solutions
7.5.4 BioLife Solutions Cell and Gene Supply Chain Solutions Revenue (US$ Million) & (2019-2024)
7.5.5 BioLife Solutions Recent Developments
7.6 BioTherapies
7.6.1 BioTherapies Profile
7.6.2 BioTherapies Main Business
7.6.3 BioTherapies Cell and Gene Supply Chain Solutions Products, Services and Solutions
7.6.4 BioTherapies Cell and Gene Supply Chain Solutions Revenue (US$ Million) & (2019-2024)
7.6.5 BioTherapies Recent Developments
7.7 Azenta US, Inc.
7.7.1 Azenta US, Inc. Profile
7.7.2 Azenta US, Inc. Main Business
7.7.3 Azenta US, Inc. Cell and Gene Supply Chain Solutions Products, Services and Solutions
7.7.4 Azenta US, Inc. Cell and Gene Supply Chain Solutions Revenue (US$ Million) & (2019-2024)
7.7.5 Azenta US, Inc. Recent Developments
7.8 Clarkston Consulting
7.8.1 Clarkston Consulting Profile
7.8.2 Clarkston Consulting Main Business
7.8.3 Clarkston Consulting Cell and Gene Supply Chain Solutions Products, Services and Solutions
7.8.4 Clarkston Consulting Cell and Gene Supply Chain Solutions Revenue (US$ Million) & (2019-2024)
7.8.5 Clarkston Consulting Recent Developments
7.9 Cryoport
7.9.1 Cryoport Profile
7.9.2 Cryoport Main Business
7.9.3 Cryoport Cell and Gene Supply Chain Solutions Products, Services and Solutions
7.9.4 Cryoport Cell and Gene Supply Chain Solutions Revenue (US$ Million) & (2019-2024)
7.9.5 Cryoport Recent Developments
7.10 Haemonetics
7.10.1 Haemonetics Profile
7.10.2 Haemonetics Main Business
7.10.3 Haemonetics Cell and Gene Supply Chain Solutions Products, Services and Solutions
7.10.4 Haemonetics Cell and Gene Supply Chain Solutions Revenue (US$ Million) & (2019-2024)
7.10.5 Haemonetics Recent Developments
7.11 Hypertrust Patient Data Care
7.11.1 Hypertrust Patient Data Care Profile
7.11.2 Hypertrust Patient Data Care Main Business
7.11.3 Hypertrust Patient Data Care Cell and Gene Supply Chain Solutions Products, Services and Solutions
7.11.4 Hypertrust Patient Data Care Cell and Gene Supply Chain Solutions Revenue (US$ Million) & (2019-2024)
7.11.5 Hypertrust Patient Data Care Recent Developments
7.12 Lykan Bioscience
7.12.1 Lykan Bioscience Profile
7.12.2 Lykan Bioscience Main Business
7.12.3 Lykan Bioscience Cell and Gene Supply Chain Solutions Products, Services and Solutions
7.12.4 Lykan Bioscience Cell and Gene Supply Chain Solutions Revenue (US$ Million) & (2019-2024)
7.12.5 Lykan Bioscience Recent Developments
7.13 MAK-SYSTEM International Group
7.13.1 MAK-SYSTEM International Group Profile
7.13.2 MAK-SYSTEM International Group Main Business
7.13.3 MAK-SYSTEM International Group Cell and Gene Supply Chain Solutions Products, Services and Solutions
7.13.4 MAK-SYSTEM International Group Cell and Gene Supply Chain Solutions Revenue (US$ Million) & (2019-2024)
7.13.5 MAK-SYSTEM International Group Recent Developments
7.14 MasterControl, Inc.
7.14.1 MasterControl, Inc. Profile
7.14.2 MasterControl, Inc. Main Business
7.14.3 MasterControl, Inc. Cell and Gene Supply Chain Solutions Products, Services and Solutions
7.14.4 MasterControl, Inc. Cell and Gene Supply Chain Solutions Revenue (US$ Million) & (2019-2024)
7.14.5 MasterControl, Inc. Recent Developments
7.15 SAP
7.15.1 SAP Profile
7.15.2 SAP Main Business
7.15.3 SAP Cell and Gene Supply Chain Solutions Products, Services and Solutions
7.15.4 SAP Cell and Gene Supply Chain Solutions Revenue (US$ Million) & (2019-2024)
7.15.5 SAP Recent Developments
7.16 SAVSU Technologies, Inc.
7.16.1 SAVSU Technologies, Inc. Profile
7.16.2 SAVSU Technologies, Inc. Main Business
7.16.3 SAVSU Technologies, Inc. Cell and Gene Supply Chain Solutions Products, Services and Solutions
7.16.4 SAVSU Technologies, Inc. Cell and Gene Supply Chain Solutions Revenue (US$ Million) & (2019-2024)
7.16.5 SAVSU Technologies, Inc. Recent Developments
7.17 sedApta Group
7.17.1 sedApta Group Profile
7.17.2 sedApta Group Main Business
7.17.3 sedApta Group Cell and Gene Supply Chain Solutions Products, Services and Solutions
7.17.4 sedApta Group Cell and Gene Supply Chain Solutions Revenue (US$ Million) & (2019-2024)
7.17.5 sedApta Group Recent Developments
7.18 Stafa Cellular Therapy
7.18.1 Stafa Cellular Therapy Profile
7.18.2 Stafa Cellular Therapy Main Business
7.18.3 Stafa Cellular Therapy Cell and Gene Supply Chain Solutions Products, Services and Solutions
7.18.4 Stafa Cellular Therapy Cell and Gene Supply Chain Solutions Revenue (US$ Million) & (2019-2024)
7.18.5 Stafa Cellular Therapy Recent Developments
7.19 Title21 Health Solutions
7.19.1 Title21 Health Solutions Profile
7.19.2 Title21 Health Solutions Main Business
7.19.3 Title21 Health Solutions Cell and Gene Supply Chain Solutions Products, Services and Solutions
7.19.4 Title21 Health Solutions Cell and Gene Supply Chain Solutions Revenue (US$ Million) & (2019-2024)
7.19.5 Title21 Health Solutions Recent Developments
7.20 TraceLink, Inc.
7.20.1 TraceLink, Inc. Profile
7.20.2 TraceLink, Inc. Main Business
7.20.3 TraceLink, Inc. Cell and Gene Supply Chain Solutions Products, Services and Solutions
7.20.4 TraceLink, Inc. Cell and Gene Supply Chain Solutions Revenue (US$ Million) & (2019-2024)
7.20.5 TraceLink, Inc. Recent Developments
7.21 TrakCel Limited
7.21.1 TrakCel Limited Profile
7.21.2 TrakCel Limited Main Business
7.21.3 TrakCel Limited Cell and Gene Supply Chain Solutions Products, Services and Solutions
7.21.4 TrakCel Limited Cell and Gene Supply Chain Solutions Revenue (US$ Million) & (2019-2024)
7.21.5 TrakCel Limited Recent Developments
7.22 Vineti, Inc
7.22.1 Vineti, Inc Profile
7.22.2 Vineti, Inc Main Business
7.22.3 Vineti, Inc Cell and Gene Supply Chain Solutions Products, Services and Solutions
7.22.4 Vineti, Inc Cell and Gene Supply Chain Solutions Revenue (US$ Million) & (2019-2024)
7.22.5 Vineti, Inc Recent Developments
8 Industry Chain Analysis
8.1 Cell and Gene Supply Chain Solutions Industrial Chain
8.2 Cell and Gene Supply Chain Solutions Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Cell and Gene Supply Chain Solutions Sales Model
8.5.2 Sales Channel
8.5.3 Cell and Gene Supply Chain Solutions Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. Cell and Gene Supply Chain Solutions Market Trends
Table 2. Cell and Gene Supply Chain Solutions Market Drivers & Opportunity
Table 3. Cell and Gene Supply Chain Solutions Market Challenges
Table 4. Cell and Gene Supply Chain Solutions Market Restraints
Table 5. Global Cell and Gene Supply Chain Solutions Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Cell and Gene Supply Chain Solutions Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Cell and Gene Supply Chain Solutions Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Cell and Gene Supply Chain Solutions Product Type
Table 9. Key Companies Time to Begin Mass Production of Cell and Gene Supply Chain Solutions
Table 10. Global Cell and Gene Supply Chain Solutions Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Supply Chain Solutions as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Cell and Gene Supply Chain Solutions Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Cell and Gene Supply Chain Solutions Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Cell and Gene Supply Chain Solutions Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Cell and Gene Supply Chain Solutions Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Cell and Gene Supply Chain Solutions Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Cell and Gene Supply Chain Solutions Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Cell and Gene Supply Chain Solutions Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Cell and Gene Supply Chain Solutions Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Cell and Gene Supply Chain Solutions Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Cell and Gene Supply Chain Solutions Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Cell and Gene Supply Chain Solutions Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Cell and Gene Supply Chain Solutions Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Cell and Gene Supply Chain Solutions Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Cell and Gene Supply Chain Solutions Sales Value by Region (2019-2024) & (%)
Table 27. Global Cell and Gene Supply Chain Solutions Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Cell and Gene Supply Chain Solutions Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Cell and Gene Supply Chain Solutions Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Cell and Gene Supply Chain Solutions Sales Value, (2025-2030) & (US$ Million)
Table 31. Arvato Basic Information List
Table 32. Arvato Description and Business Overview
Table 33. Arvato Cell and Gene Supply Chain Solutions Products, Services and Solutions
Table 34. Revenue (US$ Million) in Cell and Gene Supply Chain Solutions Business of Arvato (2019-2024)
Table 35. Arvato Recent Developments
Table 36. Biocair Basic Information List
Table 37. Biocair Description and Business Overview
Table 38. Biocair Cell and Gene Supply Chain Solutions Products, Services and Solutions
Table 39. Revenue (US$ Million) in Cell and Gene Supply Chain Solutions Business of Biocair (2019-2024)
Table 40. Biocair Recent Developments
Table 41. CSafe Global, LLC Basic Information List
Table 42. CSafe Global, LLC Description and Business Overview
Table 43. CSafe Global, LLC Cell and Gene Supply Chain Solutions Products, Services and Solutions
Table 44. Revenue (US$ Million) in Cell and Gene Supply Chain Solutions Business of CSafe Global, LLC (2019-2024)
Table 45. CSafe Global, LLC Recent Developments
Table 46. Catalent Basic Information List
Table 47. Catalent Description and Business Overview
Table 48. Catalent Cell and Gene Supply Chain Solutions Products, Services and Solutions
Table 49. Revenue (US$ Million) in Cell and Gene Supply Chain Solutions Business of Catalent (2019-2024)
Table 50. Catalent Recent Developments
Table 51. BioLife Solutions Basic Information List
Table 52. BioLife Solutions Description and Business Overview
Table 53. BioLife Solutions Cell and Gene Supply Chain Solutions Products, Services and Solutions
Table 54. Revenue (US$ Million) in Cell and Gene Supply Chain Solutions Business of BioLife Solutions (2019-2024)
Table 55. BioLife Solutions Recent Developments
Table 56. BioTherapies Basic Information List
Table 57. BioTherapies Description and Business Overview
Table 58. BioTherapies Cell and Gene Supply Chain Solutions Products, Services and Solutions
Table 59. Revenue (US$ Million) in Cell and Gene Supply Chain Solutions Business of BioTherapies (2019-2024)
Table 60. BioTherapies Recent Developments
Table 61. Azenta US, Inc. Basic Information List
Table 62. Azenta US, Inc. Description and Business Overview
Table 63. Azenta US, Inc. Cell and Gene Supply Chain Solutions Products, Services and Solutions
Table 64. Revenue (US$ Million) in Cell and Gene Supply Chain Solutions Business of Azenta US, Inc. (2019-2024)
Table 65. Azenta US, Inc. Recent Developments
Table 66. Clarkston Consulting Basic Information List
Table 67. Clarkston Consulting Description and Business Overview
Table 68. Clarkston Consulting Cell and Gene Supply Chain Solutions Products, Services and Solutions
Table 69. Revenue (US$ Million) in Cell and Gene Supply Chain Solutions Business of Clarkston Consulting (2019-2024)
Table 70. Clarkston Consulting Recent Developments
Table 71. Cryoport Basic Information List
Table 72. Cryoport Description and Business Overview
Table 73. Cryoport Cell and Gene Supply Chain Solutions Products, Services and Solutions
Table 74. Revenue (US$ Million) in Cell and Gene Supply Chain Solutions Business of Cryoport (2019-2024)
Table 75. Cryoport Recent Developments
Table 76. Haemonetics Basic Information List
Table 77. Haemonetics Description and Business Overview
Table 78. Haemonetics Cell and Gene Supply Chain Solutions Products, Services and Solutions
Table 79. Revenue (US$ Million) in Cell and Gene Supply Chain Solutions Business of Haemonetics (2019-2024)
Table 80. Haemonetics Recent Developments
Table 81. Hypertrust Patient Data Care Basic Information List
Table 82. Hypertrust Patient Data Care Description and Business Overview
Table 83. Hypertrust Patient Data Care Cell and Gene Supply Chain Solutions Products, Services and Solutions
Table 84. Revenue (US$ Million) in Cell and Gene Supply Chain Solutions Business of Hypertrust Patient Data Care (2019-2024)
Table 85. Hypertrust Patient Data Care Recent Developments
Table 86. Lykan Bioscience Basic Information List
Table 87. Lykan Bioscience Description and Business Overview
Table 88. Lykan Bioscience Cell and Gene Supply Chain Solutions Products, Services and Solutions
Table 89. Revenue (US$ Million) in Cell and Gene Supply Chain Solutions Business of Lykan Bioscience (2019-2024)
Table 90. Lykan Bioscience Recent Developments
Table 91. MAK-SYSTEM International Group Basic Information List
Table 92. MAK-SYSTEM International Group Description and Business Overview
Table 93. MAK-SYSTEM International Group Cell and Gene Supply Chain Solutions Products, Services and Solutions
Table 94. Revenue (US$ Million) in Cell and Gene Supply Chain Solutions Business of MAK-SYSTEM International Group (2019-2024)
Table 95. MAK-SYSTEM International Group Recent Developments
Table 96. MasterControl, Inc. Basic Information List
Table 97. MasterControl, Inc. Description and Business Overview
Table 98. MasterControl, Inc. Cell and Gene Supply Chain Solutions Products, Services and Solutions
Table 99. Revenue (US$ Million) in Cell and Gene Supply Chain Solutions Business of MasterControl, Inc. (2019-2024)
Table 100. MasterControl, Inc. Recent Developments
Table 101. SAP Basic Information List
Table 102. SAP Description and Business Overview
Table 103. SAP Cell and Gene Supply Chain Solutions Products, Services and Solutions
Table 104. Revenue (US$ Million) in Cell and Gene Supply Chain Solutions Business of SAP (2019-2024)
Table 105. SAP Recent Developments
Table 106. SAVSU Technologies, Inc. Basic Information List
Table 107. SAVSU Technologies, Inc. Description and Business Overview
Table 108. SAVSU Technologies, Inc. Cell and Gene Supply Chain Solutions Products, Services and Solutions
Table 109. Revenue (US$ Million) in Cell and Gene Supply Chain Solutions Business of SAVSU Technologies, Inc. (2019-2024)
Table 110. SAVSU Technologies, Inc. Recent Developments
Table 111. sedApta Group Basic Information List
Table 112. sedApta Group Description and Business Overview
Table 113. sedApta Group Cell and Gene Supply Chain Solutions Products, Services and Solutions
Table 114. Revenue (US$ Million) in Cell and Gene Supply Chain Solutions Business of sedApta Group (2019-2024)
Table 115. sedApta Group Recent Developments
Table 116. Stafa Cellular Therapy Basic Information List
Table 117. Stafa Cellular Therapy Description and Business Overview
Table 118. Stafa Cellular Therapy Cell and Gene Supply Chain Solutions Products, Services and Solutions
Table 119. Revenue (US$ Million) in Cell and Gene Supply Chain Solutions Business of Stafa Cellular Therapy (2019-2024)
Table 120. Stafa Cellular Therapy Recent Developments
Table 121. Title21 Health Solutions Basic Information List
Table 122. Title21 Health Solutions Description and Business Overview
Table 123. Title21 Health Solutions Cell and Gene Supply Chain Solutions Products, Services and Solutions
Table 124. Revenue (US$ Million) in Cell and Gene Supply Chain Solutions Business of Title21 Health Solutions (2019-2024)
Table 125. Title21 Health Solutions Recent Developments
Table 126. TraceLink, Inc. Basic Information List
Table 127. TraceLink, Inc. Description and Business Overview
Table 128. TraceLink, Inc. Cell and Gene Supply Chain Solutions Products, Services and Solutions
Table 129. Revenue (US$ Million) in Cell and Gene Supply Chain Solutions Business of TraceLink, Inc. (2019-2024)
Table 130. TraceLink, Inc. Recent Developments
Table 131. TrakCel Limited Basic Information List
Table 132. TrakCel Limited Description and Business Overview
Table 133. TrakCel Limited Cell and Gene Supply Chain Solutions Products, Services and Solutions
Table 134. Revenue (US$ Million) in Cell and Gene Supply Chain Solutions Business of TrakCel Limited (2019-2024)
Table 135. TrakCel Limited Recent Developments
Table 136. Vineti, Inc Basic Information List
Table 137. Vineti, Inc Description and Business Overview
Table 138. Vineti, Inc Cell and Gene Supply Chain Solutions Products, Services and Solutions
Table 139. Revenue (US$ Million) in Cell and Gene Supply Chain Solutions Business of Vineti, Inc (2019-2024)
Table 140. Vineti, Inc Recent Developments
Table 141. Key Raw Materials Lists
Table 142. Raw Materials Key Suppliers Lists
Table 143. Cell and Gene Supply Chain Solutions Downstream Customers
Table 144. Cell and Gene Supply Chain Solutions Distributors List
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
Table 148. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Cell and Gene Supply Chain Solutions Product Picture
Figure 2. Global Cell and Gene Supply Chain Solutions Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Cell and Gene Supply Chain Solutions Sales Value (2019-2030) & (US$ Million)
Figure 4. Cell and Gene Supply Chain Solutions Report Years Considered
Figure 5. Global Cell and Gene Supply Chain Solutions Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Cell and Gene Supply Chain Solutions Revenue in 2023
Figure 7. Cell and Gene Supply Chain Solutions Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Cloud-Based Picture
Figure 9. On-Premises Picture
Figure 10. Global Cell and Gene Supply Chain Solutions Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Cell and Gene Supply Chain Solutions Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of Biobank/ Cell-bank
Figure 13. Product Picture of Hospitals
Figure 14. Product Picture of Research Institutes
Figure 15. Product Picture of Cell Therapy Labs
Figure 16. Product Picture of Others
Figure 17. Global Cell and Gene Supply Chain Solutions Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Cell and Gene Supply Chain Solutions Sales Value Market Share by Application, 2023 & 2030
Figure 19. North America Cell and Gene Supply Chain Solutions Sales Value (2019-2030) & (US$ Million)
Figure 20. North America Cell and Gene Supply Chain Solutions Sales Value by Country (%), 2023 VS 2030
Figure 21. Europe Cell and Gene Supply Chain Solutions Sales Value (2019-2030) & (US$ Million)
Figure 22. Europe Cell and Gene Supply Chain Solutions Sales Value by Country (%), 2023 VS 2030
Figure 23. Asia Pacific Cell and Gene Supply Chain Solutions Sales Value (2019-2030) & (US$ Million)
Figure 24. Asia Pacific Cell and Gene Supply Chain Solutions Sales Value by Country (%), 2023 VS 2030
Figure 25. South America Cell and Gene Supply Chain Solutions Sales Value (2019-2030) & (US$ Million)
Figure 26. South America Cell and Gene Supply Chain Solutions Sales Value by Country (%), 2023 VS 2030
Figure 27. Middle East & Africa Cell and Gene Supply Chain Solutions Sales Value (2019-2030) & (US$ Million)
Figure 28. Middle East & Africa Cell and Gene Supply Chain Solutions Sales Value by Country (%), 2023 VS 2030
Figure 29. Key Countries/Regions Cell and Gene Supply Chain Solutions Sales Value (%), (2019-2030)
Figure 30. United States Cell and Gene Supply Chain Solutions Sales Value, (2019-2030) & (US$ Million)
Figure 31. United States Cell and Gene Supply Chain Solutions Sales Value by Type (%), 2023 VS 2030
Figure 32. United States Cell and Gene Supply Chain Solutions Sales Value by Application (%), 2023 VS 2030
Figure 33. Europe Cell and Gene Supply Chain Solutions Sales Value, (2019-2030) & (US$ Million)
Figure 34. Europe Cell and Gene Supply Chain Solutions Sales Value by Type (%), 2023 VS 2030
Figure 35. Europe Cell and Gene Supply Chain Solutions Sales Value by Application (%), 2023 VS 2030
Figure 36. China Cell and Gene Supply Chain Solutions Sales Value, (2019-2030) & (US$ Million)
Figure 37. China Cell and Gene Supply Chain Solutions Sales Value by Type (%), 2023 VS 2030
Figure 38. China Cell and Gene Supply Chain Solutions Sales Value by Application (%), 2023 VS 2030
Figure 39. Japan Cell and Gene Supply Chain Solutions Sales Value, (2019-2030) & (US$ Million)
Figure 40. Japan Cell and Gene Supply Chain Solutions Sales Value by Type (%), 2023 VS 2030
Figure 41. Japan Cell and Gene Supply Chain Solutions Sales Value by Application (%), 2023 VS 2030
Figure 42. South Korea Cell and Gene Supply Chain Solutions Sales Value, (2019-2030) & (US$ Million)
Figure 43. South Korea Cell and Gene Supply Chain Solutions Sales Value by Type (%), 2023 VS 2030
Figure 44. South Korea Cell and Gene Supply Chain Solutions Sales Value by Application (%), 2023 VS 2030
Figure 45. Southeast Asia Cell and Gene Supply Chain Solutions Sales Value, (2019-2030) & (US$ Million)
Figure 46. Southeast Asia Cell and Gene Supply Chain Solutions Sales Value by Type (%), 2023 VS 2030
Figure 47. Southeast Asia Cell and Gene Supply Chain Solutions Sales Value by Application (%), 2023 VS 2030
Figure 48. India Cell and Gene Supply Chain Solutions Sales Value, (2019-2030) & (US$ Million)
Figure 49. India Cell and Gene Supply Chain Solutions Sales Value by Type (%), 2023 VS 2030
Figure 50. India Cell and Gene Supply Chain Solutions Sales Value by Application (%), 2023 VS 2030
Figure 51. Cell and Gene Supply Chain Solutions Industrial Chain
Figure 52. Cell and Gene Supply Chain Solutions Manufacturing Cost Structure
Figure 53. Channels of Distribution (Direct Sales, and Distribution)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data TriangulationDescription
Cell and gene supply chain solutions help mitigate distribution risks with features designed to improve product handling and unforeseen disruptions.Goods and services are produced and sold as inexpensively as possible, in quantities demanded by the market.
The global market for Cell and Gene Supply Chain Solutions was estimated to be worth US$ 1230 million in 2023 and is forecast to a readjusted size of US$ 1816.6 million by 2030 with a CAGR of 5.6% during the forecast period 2024-2030
The global cell and gene supply chain solutions market refers to the industry that provides specialized logistics, storage, and distribution services for cell and gene therapies. These therapies involve the use of living cells or genetic material to treat, cure, or prevent diseases. As cell and gene therapies gain momentum, the need for efficient and reliable supply chain solutions becomes crucial. Here’s an overview of the market:
Market Overview: The cell and gene supply chain solutions market has experienced significant growth in recent years due to the rapid development and commercialization of cell and gene therapies. These therapies, which include gene editing, cell-based immunotherapies, regenerative medicine, and gene therapies, require proper handling, storage, transportation, and tracking to ensure their integrity and efficacy.
Challenges in the Supply Chain: Cell and gene therapies have unique requirements that pose challenges to the supply chain. These challenges include maintaining the integrity of living cells or genetic materials during transportation, ensuring proper storage conditions, managing the complex logistics of personalized therapies, complying with regulatory requirements, and establishing effective traceability systems.
Supply Chain Solutions: Companies in the cell and gene supply chain solutions market offer a range of services to address these challenges. These services include specialized cold chain logistics, temperature-controlled storage facilities, cryopreservation solutions, packaging and labeling, transportation management, and real-time monitoring of therapies throughout the supply chain. Additionally, they provide expertise in regulatory compliance and documentation required for cell and gene therapies.
Market Players: The market for cell and gene supply chain solutions is comprised of various stakeholders, including logistics companies, specialized courier services, storage and distribution providers, and technology providers. Some companies focus solely on cell and gene therapies, while others offer supply chain solutions for a broader range of healthcare products.
Integration of Technology: Technology plays a key role in optimizing the cell and gene supply chain. Companies leverage advanced information systems, data analytics, and real-time monitoring solutions to ensure the safe and timely delivery of therapies. Furthermore, emerging technologies such as blockchain are being explored to enhance traceability and transparency in the supply chain.
Regulatory Environment: The cell and gene supply chain solutions market is influenced by regulatory frameworks governing the transportation, storage, and distribution of biological products, including cell and gene therapies. Companies in this market need to adhere to quality and safety standards, maintain documentation and traceability, and comply with regulations specific to each region or country.
Collaboration and Partnerships: Due to the complexity of cell and gene therapies, collaborations and partnerships between different stakeholders are crucial. This includes collaborations between therapy developers, logistics providers, storage facilities, and clinical sites to ensure efficient supply chain management and seamless delivery of therapies to patients.
Market Outlook: The global cell and gene supply chain solutions market is expected to experience substantial growth in the coming years. Factors driving this growth include the increasing number of approved cell and gene therapies, advancements in cold chain and storage technologies, growing investments in the biopharmaceutical sector, and rising demand for personalized medicine.The global cell and gene supply chain solutions market refers to the industry that provides specialized logistics, storage, and distribution services for cell and gene therapies. These therapies involve the use of living cells or genetic material to treat, cure, or prevent diseases. As cell and gene therapies gain momentum, the need for efficient and reliable supply chain solutions becomes crucial. Here’s an overview of the market:
Market Overview: The cell and gene supply chain solutions market has experienced significant growth in recent years due to the rapid development and commercialization of cell and gene therapies. These therapies, which include gene editing, cell-based immunotherapies, regenerative medicine, and gene therapies, require proper handling, storage, transportation, and tracking to ensure their integrity and efficacy.
Challenges in the Supply Chain: Cell and gene therapies have unique requirements that pose challenges to the supply chain. These challenges include maintaining the integrity of living cells or genetic materials during transportation, ensuring proper storage conditions, managing the complex logistics of personalized therapies, complying with regulatory requirements, and establishing effective traceability systems.
Supply Chain Solutions: Companies in the cell and gene supply chain solutions market offer a range of services to address these challenges. These services include specialized cold chain logistics, temperature-controlled storage facilities, cryopreservation solutions, packaging and labeling, transportation management, and real-time monitoring of therapies throughout the supply chain. Additionally, they provide expertise in regulatory compliance and documentation required for cell and gene therapies.
Market Players: The market for cell and gene supply chain solutions is comprised of various stakeholders, including logistics companies, specialized courier services, storage and distribution providers, and technology providers. Some companies focus solely on cell and gene therapies, while others offer supply chain solutions for a broader range of healthcare products.
Integration of Technology: Technology plays a key role in optimizing the cell and gene supply chain. Companies leverage advanced information systems, data analytics, and real-time monitoring solutions to ensure the safe and timely delivery of therapies. Furthermore, emerging technologies such as blockchain are being explored to enhance traceability and transparency in the supply chain.
Regulatory Environment: The cell and gene supply chain solutions market is influenced by regulatory frameworks governing the transportation, storage, and distribution of biological products, including cell and gene therapies. Companies in this market need to adhere to quality and safety standards, maintain documentation and traceability, and comply with regulations specific to each region or country.
Collaboration and Partnerships: Due to the complexity of cell and gene therapies, collaborations and partnerships between different stakeholders are crucial. This includes collaborations between therapy developers, logistics providers, storage facilities, and clinical sites to ensure efficient supply chain management and seamless delivery of therapies to patients.
Market Outlook: The global cell and gene supply chain solutions market is expected to experience substantial growth in the coming years. Factors driving this growth include the increasing number of approved cell and gene therapies, advancements in cold chain and storage technologies, growing investments in the biopharmaceutical sector, and rising demand for personalized medicine.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cell and Gene Supply Chain Solutions, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Cell and Gene Supply Chain Solutions by region & country, by Type, and by Application.
The Cell and Gene Supply Chain Solutions market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell and Gene Supply Chain Solutions.
Market Segmentation
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Cell and Gene Supply Chain Solutions manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Cell and Gene Supply Chain Solutions in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Cell and Gene Supply Chain Solutions in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Related Reports
Global Cell and Gene Supply Chain Solutions Market Research Report 2024
Cell and gene supply chain solutions help mitigate distribution risks with features designed to improve product handling and unforeseen disruptions.Goods and services are produced and sold as inexpensively as possible, in quantities demanded by the market.
Published: 2024-02-21
Pages: 100
USD 2900.00
(Single User License)
Global Cell and Gene Supply Chain Solutions Market Insights, Forecast to 2030
Cell and gene supply chain solutions help mitigate distribution risks with features designed to improve product handling and unforeseen disruptions.Goods and services are produced and sold as inexpensively as possible, in quantities demanded by the market.
Published: 2024-04-10
Pages: 128
USD 4900.00
(Single User License)
Global Cell and Gene Supply Chain Solutions Market Research Report 2025
The global market for Cell and Gene Supply Chain Solutions was valued at US$ 1376 million in the year 2024 and is projected to reach a revised size of US$ 2004 million by 2031, growing at a CAGR of 5.6% during the forecast period.
Published: 2025-03-03
Pages: 102
USD 2900.00
(Single User License)
Cell and Gene Supply Chain Solutions- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Cell and Gene Supply Chain Solutions was estimated to be worth US$ 1376 million in 2024 and is forecast to a readjusted size of US$ 2004 million by 2031 with a CAGR of 5.6% during the forecast period 2025-2031.
Published: 2025-03-03
Pages: 155
USD 3950.00
(Single User License)
Global Cell and Gene Supply Chain Solutions Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Cell and Gene Supply Chain Solutions market size was US$ 1376 million in 2024 and is forecast to a readjusted size of US$ 2004 million by 2031 with a CAGR of 5.6% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 114
USD 4250.00
(Single User License)
Global Cell and Gene Supply Chain Solutions Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Cell and Gene Supply Chain Solutions market is projected to grow from US$ 1376 million in 2024 to US$ 2004 million by 2031, at a CAGR of 5.6% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-03
Pages: 163
USD 4900.00
(Single User License)
Global Cell and Gene Supply Chain Solutions Market Research Report 2026
The global Cell and Gene Supply Chain Solutions market was valued at US$ 1445 million in 2025 and is anticipated to reach US$ 2105 million by 2032, at a CAGR of 5.6% from 2026 to 2032.
Published: 2026-02-11
Pages: 154
USD 2900.00
(Single User License)
Cell and Gene Supply Chain Solutions - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Cell and Gene Supply Chain Solutions was estimated to be worth US$ 1445 million in 2025 and is projected to reach US$ 2105 million, growing at a CAGR of 5.6% from 2026 to 2032.
Published: 2026-02-11
Pages: 142
USD 3950.00
(Single User License)
Global Cell and Gene Supply Chain Solutions Market Research Report 2024
Cell and gene supply chain solutions help mitigate distribution risks with features designed to improve product handling and unforeseen disruptions.Goods and services are produced and sold as inexpensively as possible, in quantities demanded by the market.
Published: 2024-02-21
Pages: 100
USD 2900.00 ()Global Cell and Gene Supply Chain Solutions Market Insights, Forecast to 2030
Cell and gene supply chain solutions help mitigate distribution risks with features designed to improve product handling and unforeseen disruptions.Goods and services are produced and sold as inexpensively as possible, in quantities demanded by the market.
Published: 2024-04-10
Pages: 128
USD 4900.00 ()Global Cell and Gene Supply Chain Solutions Market Research Report 2025
The global market for Cell and Gene Supply Chain Solutions was valued at US$ 1376 million in the year 2024 and is projected to reach a revised size of US$ 2004 million by 2031, growing at a CAGR of 5.6% during the forecast period.
Published: 2025-03-03
Pages: 102
USD 2900.00 ()Cell and Gene Supply Chain Solutions- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Cell and Gene Supply Chain Solutions was estimated to be worth US$ 1376 million in 2024 and is forecast to a readjusted size of US$ 2004 million by 2031 with a CAGR of 5.6% during the forecast period 2025-2031.
Published: 2025-03-03
Pages: 155
USD 3950.00 ()Global Cell and Gene Supply Chain Solutions Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Cell and Gene Supply Chain Solutions market size was US$ 1376 million in 2024 and is forecast to a readjusted size of US$ 2004 million by 2031 with a CAGR of 5.6% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 114
USD 4250.00 ()Global Cell and Gene Supply Chain Solutions Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Cell and Gene Supply Chain Solutions market is projected to grow from US$ 1376 million in 2024 to US$ 2004 million by 2031, at a CAGR of 5.6% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-03
Pages: 163
USD 4900.00 ()Global Cell and Gene Supply Chain Solutions Market Research Report 2026
The global Cell and Gene Supply Chain Solutions market was valued at US$ 1445 million in 2025 and is anticipated to reach US$ 2105 million by 2032, at a CAGR of 5.6% from 2026 to 2032.
Published: 2026-02-11
Pages: 154
USD 2900.00 ()Cell and Gene Supply Chain Solutions - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Cell and Gene Supply Chain Solutions was estimated to be worth US$ 1445 million in 2025 and is projected to reach US$ 2105 million, growing at a CAGR of 5.6% from 2026 to 2032.
Published: 2026-02-11
Pages: 142
USD 3950.00 ()
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
Have a question?
General Email:
WHAT QYRESEARCH OFFER?
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
INTEREST IN THIS REPORT?
Get A Free Sample >>
WHY QYR?
Fastest report delivery service
More than 19 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database